Estimation of radiation-induced health hazards from a "dirty bomb" attack with radiocesium under different assault and rescue conditions.

Acute radiation sickness Combined injuries Dirty bomb Medical NRBC protection Radiological emergency Radionuclide incorporation Terrorism Triage

Journal

Military Medical Research
ISSN: 2054-9369
Titre abrégé: Mil Med Res
Pays: England
ID NLM: 101643181

Informations de publication

Date de publication:
09 12 2021
Historique:
received: 04 02 2021
accepted: 14 10 2021
entrez: 9 12 2021
pubmed: 10 12 2021
medline: 24 3 2022
Statut: epublish

Résumé

In the case of a terrorist attack by a "dirty bomb", blast injuries, external irradiation and the incorporation of radioactivity are to be expected. Departing from information about the radiological attack scenario with cesium-137 in the U.S. National Scenario Planning Guide, we estimated the radiological doses absorbed. Similar calculations were performed for a smaller plume size and a detonation in a subway. For conditions as described in the U.S. scenario, the committed effective dose amounted to a maximum of 848 mSv, even for very unfavorable conditions. Red bone marrow equivalent doses are insufficient to induce acute radiation sickness (ARS). In the case of a smaller plume size, the ARS threshold may be exceeded in some cases. In a subway bombing, doses are much higher and the occurrence of ARS should be expected. The health hazards from a dirty bomb attack will depend on the location and the explosive device. The derived Haddon matrix indicates that preparing for such an event includes education of all the medical staff about radiation effects, the time lines of radiation damages and the treatment priorities. Further determinants of the outcome include rapid evacuation even from difficult locations, the availability of a specific triage tool to rapidly identify victims at risk for ARS, the availability of an antidote stockpile and dedicated hospital beds to treat seriously irradiated victims.

Identifiants

pubmed: 34879871
doi: 10.1186/s40779-021-00349-w
pii: 10.1186/s40779-021-00349-w
pmc: PMC8656004
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

65

Informations de copyright

© 2021. The Author(s).

Références

Health Phys. 2016 Aug;111(2):204-11
pubmed: 27356066
Radiat Res. 2012 Mar;177(3):229-43
pubmed: 22171960
Radiat Prot Dosimetry. 2007;125(1-4):194-7
pubmed: 17132655
Appl Radiat Isot. 2005 Jun;62(6):829-46
pubmed: 15799861
Mil Med Res. 2021 Jan 17;8(1):3
pubmed: 33455578
Drug Res (Stuttg). 2016 Nov;66(11):607-613
pubmed: 27532439
Ann Burns Fire Disasters. 2017 Dec 31;30(4):256-260
pubmed: 29983676
Ann Surg. 1988 Nov;208(5):569-76
pubmed: 3056287
Appl Opt. 1983 Jan 1;22(1):95-102
pubmed: 18195752
Environ Health Perspect. 2005 May;113(5):561-6
pubmed: 15866764
Inj Prev. 1998 Dec;4(4):302-7
pubmed: 9887425
Eur J Emerg Med. 2007 Oct;14(5):247-55
pubmed: 17823558
Health Phys. 2014 May;106(5):592-7
pubmed: 24670908
Mil Med Res. 2018 Aug 6;5(1):27
pubmed: 30086798
Mil Med. 1997 Jan;162(1):24-6
pubmed: 9002698
Mil Med Res. 2019 Mar 31;6(1):10
pubmed: 30961671
Int J Radiat Biol. 2014 Nov;90(11):1043-7
pubmed: 24844372
Radiat Prot Dosimetry. 2018 Dec 1;182(1):90-92
pubmed: 30165461
Radiat Prot Dosimetry. 2008;131(3):297-307
pubmed: 18550515
Surg Clin North Am. 2006 Jun;86(3):601-36
pubmed: 16781272
Radiat Res. 2009 Sep;172(3):368-82
pubmed: 19708786
Toxicol Lett. 2019 Oct 1;313:159-168
pubmed: 31276769
Proc (Bayl Univ Med Cent). 2013 Apr;26(2):120-3
pubmed: 23543966
Radiat Res. 1993 Sep;135(3):418-30
pubmed: 8378535
Am J Disaster Med. 2017 Fall;12(4):227-241
pubmed: 29468625
Mil Med Res. 2019 Jun 14;6(1):18
pubmed: 31200760
Health Phys. 2007 Jul;93(1):1-16
pubmed: 17563488
Radiat Res. 1999 Oct;152(4):374-89
pubmed: 10477914
J Environ Radioact. 2009 Dec;100(12):1005-11
pubmed: 19427717
Epidemiol Rev. 2003;25:60-4
pubmed: 12940231
Resuscitation. 2014 May;85(5):602-5
pubmed: 24530250
Environ Int. 2021 Jan;146:106278
pubmed: 33271440
Health Phys. 2010 Aug;99(2):105-23
pubmed: 20622547
Radiat Environ Biophys. 2013 Nov;52(4):435-49
pubmed: 23903347
World Health Stat Q. 1996;49(1):7-16
pubmed: 8896251
Adv Wound Care (New Rochelle). 2017 Jan 1;6(1):1-9
pubmed: 28116223
Int J Epidemiol. 2007 Oct;36(5):1126-35
pubmed: 17666424
Radiat Res. 2003 Oct;160(4):381-407
pubmed: 12968934
J Environ Radioact. 2014 Oct;136:41-55
pubmed: 24878719
Ann Emerg Med. 2004 Feb;43(2):263-73
pubmed: 14747818
Drug Res (Stuttg). 2018 Feb;68(2):89-99
pubmed: 29036734

Auteurs

Alexis Rump (A)

Bundeswehr Institute of Radiobiology, Neuherberg Str. 11, 80937, Munich, Germany. AlexisRump@bundeswehr.org.

Stefan Eder (S)

Bundeswehr Institute of Radiobiology, Neuherberg Str. 11, 80937, Munich, Germany.

Cornelius Hermann (C)

Bundeswehr Institute of Radiobiology, Neuherberg Str. 11, 80937, Munich, Germany.

Andreas Lamkowski (A)

Bundeswehr Institute of Radiobiology, Neuherberg Str. 11, 80937, Munich, Germany.

Patrick Ostheim (P)

Bundeswehr Institute of Radiobiology, Neuherberg Str. 11, 80937, Munich, Germany.

Michael Abend (M)

Bundeswehr Institute of Radiobiology, Neuherberg Str. 11, 80937, Munich, Germany.

Matthias Port (M)

Bundeswehr Institute of Radiobiology, Neuherberg Str. 11, 80937, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH